Market Place
Sourcing Support
Students Week at Tiefenbacher Group – Connecting Global Talents!
17 Dec 2025 //
PRESS RELEASE
Tiefenbacher Group at CPHI Frankfurt 2025
24 Oct 2025 //
PRESS RELEASE
Celebrating the Spirit of Diwali at Tiefenbacher Laboratories
20 Oct 2025 //
PRESS RELEASE
Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy
10 Oct 2025 //
PRESS RELEASE
Tiefenbacher Celebrates World Science Day
10 Sep 2025 //
PRESS REEASE
Tiefenbacher Group Career Stories No 3
29 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group celebrates World Humanitarian Day
20 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group Career Stories No 2
15 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group Career Stories No 1
05 Aug 2025 //
PRESS RELEASE
Tiefenbacher New Market Launch: Buprenorphine Patches in SA
01 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group Self-Care Day
25 Jul 2025 //
PRESS RELEASE
Pioneering Healthcare at Tiefenbacher Group
23 Jul 2025 //
PRESS RELEASE
Tiefenbacher Group about affordable medicines
10 Jul 2025 //
PRESS RELEASE
Tiefenbacher Group International Social Day
01 Jul 2025 //
PRESS RELEASE
Tiefenbacher Laboratories Supporting Women’s Health
28 May 2025 //
PRESS RELEASE
Tiefenbacher Group celebrates World Health Day
07 Apr 2025 //
PRESS RELEASE
Tiefenbacher Group celebrating new buildings in Hyderabad
25 Mar 2025 //
PRESS RELEASE
Tiefenbacher, OnDosis & Star celebrate iF Design Award for OYSTA
10 Mar 2025 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch: Varenicline in UK
05 Feb 2025 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine
30 Jan 2025 //
PRESS RELEASE
Tiefenbacher Group and Pharmacists Without Borders
21 Nov 2024 //
PRESS RELEASE
Pioneering Healthcare at Tiefenbacher Group
02 Oct 2024 //
PRESS RELEASE
Tiefenbacher Pharma New Market Launch Ezetimibe/Atorvastatin
18 Sep 2024 //
PRESS RELEASE
Tiefenbacher Group Earns EcoVadis Silver Medal!
09 Sep 2024 //
PRESS RELEASE
Tiefenbacher PharmaFirst to Market Launch Varenicline in Europe
22 Aug 2024 //
PRESS RELEASE
Tiefenbacher Group partnering with Pharmacists Without Borders
01 Aug 2024 //
PRESS RELEASE
Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis
08 May 2024 //
PRESS RELEASE
Tiefenbacher Group Renovation Of Headquarters In Hamburg
02 May 2024 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.
09 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
08 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group awarded the EcoVadis Silver Medal!
19 Mar 2024 //
PRESS RELEASE
Tiefenbacher Group on awareness for rare disease day
29 Feb 2024 //
PRESS RELEASE
Tiefenbacher Group Renovation of our Headquarters
14 Feb 2024 //
PRESS RELEASE
Aet Laboratories 20Th Anniversary Celebration
03 Jan 2024 //
PRESS RELEASE
Tiefenbacher Launch anticoagulant Rivaroxaban in Canada
16 Nov 2023 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
27 Sep 2023 //
PRESS RELEASE
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
10 May 2023 //
PRESS RELEASE
Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine
14 Mar 2023 //
PRESS RELEASE
Tiefenbacher Manufacturing Sites Have Been Successfully Registered By The UAE
25 Feb 2023 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Of The Psoriasis Apremilast
01 Dec 2022 //
PRESS RELEASE
Meet Tiefenbacher Group At Bepharma In Mexico City From October 10-12!
15 Sep 2022 //
PRESS RELEASE
Alfred E. Tiefenbacher`s Pirfenidone Receives Approval in the EMA
28 Jun 2022 //
FDA
Alfred E. Tiefenbacher` Pirfenidone AET Receives Approval in Europe
28 Jun 2022 //
EMA
Tiefenbacher Group Becomes Member Of (Psci)
24 May 2022 //
PRESS RELEASE
Tiefenbacher Group Opens New Site For Highly Potent Drugs In India
05 May 2022 //
PRESS RELEASE
Four Drugs Recommended For Approval By Chmp At April Meeting
25 Apr 2022 //
MEDWATCH
World Health Day @ Tiefenbacher Group
07 Apr 2022 //
PRESS RELEASE
Tiefenbacher Group At Dcat 2022 – Thanks For Meeting Us In New York City!
29 Mar 2022 //
PRESS RELEASE
Tiefenbacher Group Stands With Ukraine
08 Mar 2022 //
PRESS RELEASE
Tiefenbacher Group Wishes A Happy And Healthy Year 2022 From All Over The World!
04 Jan 2022 //
PRESS RELEASE
Driving Efficiency Is Key Tiefenbacher Group Enlarges Manufacturing Facilities
15 Dec 2021 //
PRESS RELEASE
Reach Out To Tiefenbacher Group At Cphi In Milan From 9-11Th Nov And Discover
06 Oct 2021 //
PRESS RELEASE
New Agreement Expands Collaboration Between Ondosis And Tiefenbacher Group
26 May 2021 //
PRESS RELEASE
New Agreement Expands Collaboration Between Ondosis And Tiefenbacher Group
19 May 2021 //
PRESS RELEASE
Spreading Of Post Covid-19 Disease "Black Fungus“ In India – Tiefenbacher Group Supports With Posaconazole Tablets
19 May 2021 //
PRESS RELEASE
Tiefenbacher Group Announces Global Launch Of Tiefenbacher Medical Devices
16 Apr 2021 //
PRESS RELEASE
Aet Pharma Us Inc. Announces Successful Approval Of Generic Posaconazole By The Food And Drug Administration (FDA)
08 Feb 2021 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Announces Global Launch Of Rivaroxaban
26 Jan 2021 //
PRESS RELEASE
International Brand Relaunch Of Tiefenbacher Group
02 Oct 2020 //
PRESS RELEASE
